Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Testing Mitochondrial-Targeted Drugs in iPSC-RPE from Patients with Age-Related Macular Degeneration

Pharmaceuticals(2022)10.3390/ph15010062Source: DataRank Database

Testing Mitochondrial-Targeted Drugs in iPSC-RPE from Patients with Age-Related Macular Degeneration is a research paper published in Pharmaceuticals (2022). On theSindex it has a DataRank of 0. It has been cited 23 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access23 citations

Download PDF

Cite:

Linked data & code

refsnp nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (5 grants)Impact (FWCI 3.72)OA: goldTopics (22)IDs (PubMed, PMC, OpenAlex)Annotations (2)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Zhaohui Geng ORCID,Madilyn R. Stahl ORCID,Rebecca J. Kapphahn,Heidi Roehrich,Sandra R. Montezuma ORCID

Live enrichment

PubMed:35056119 PMC:PMC8781759 OpenAlex:https://openalex.org/W4205637731

National Institutes of Health

Grant: P30EY11374

NIH HHS

Grant: R01EY028554

Regenerative Medicine Minnesota

Grant: 091718 TR009

National Institutes of Health

Grant: 5P30EY011374-07

CORE--MACHINE SHOP

National Institutes of Health

Grant: 5R01EY028554-02

Mitochondrial defects in the retinal pigment epithelium and the CFH risk allele for age-related macular degeneration

FWCI

3.72

Citation Percentile

0.9%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttps://www.mdpi.com/1424-8247/15/1/62/pdf?version=1641291660

publisherhttps://www.mdpi.com/1424-8247/15/1/62/pdf?version=1641291660

journalhttps://doi.org/10.3390/ph15010062

repositoryhttps://pubmed.ncbi.nlm.nih.gov/35056119

repositoryhttps://doaj.org/article/22a50d171ba84395a123b68ea9d38512

Fields of Study

Retinal Diseases and TreatmentsMitochondrial Function and PathologyRetinal Development and Disorders0301 basic medicine03 medical and health sciences

Keywords

Macular degenerationMedicineOphthalmologyMitochondrial DNAKearns–Sayre syndromeBioinformaticsBiologyGeneticsGeneAge-related macular degenerationretinal pigment epitheliumHuman-induced Pluripotent Stem CellsPersonalized Drug TestingRS1-441Pharmacy and materia medicaRArticle

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being